|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2011-2-4
|
|
pubmed:abstractText |
To assess the effectiveness of the pandemic influenza A/H1N1 vaccine used in Canada during autumn 2009.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/21292718-16669132,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21292718-17081662,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21292718-19086914,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21292718-19460673,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21292718-20236548,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21292718-20386731,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21292718-20460094,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21292718-20508026,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21292718-20629771,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21292718-21303882,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21292718-3879673,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21292718-7975853
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1468-5833
|
|
pubmed:author |
pubmed-author:BastienNathalieN,
pubmed-author:CharestHuguesH,
pubmed-author:CrowcroftNatashaN,
pubmed-author:De SerresGastonG,
pubmed-author:DickinsonJames AJA,
pubmed-author:FonsecaKevinK,
pubmed-author:GubbayJonathan BJB,
pubmed-author:HottesTravis STS,
pubmed-author:JanjuaNaveed ZNZ,
pubmed-author:KwindtTrijntje LTL,
pubmed-author:LiYanY,
pubmed-author:PetricMartinM,
pubmed-author:SkowronskiDanuta MDM,
pubmed-author:TangPatrickP
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
342
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
c7297
|
|
pubmed:dateRevised |
2011-7-25
|
|
pubmed:meshHeading |
pubmed-meshheading:21292718-Adjuvants, Immunologic,
pubmed-meshheading:21292718-Adolescent,
pubmed-meshheading:21292718-Adult,
pubmed-meshheading:21292718-Aged,
pubmed-meshheading:21292718-Canada,
pubmed-meshheading:21292718-Case-Control Studies,
pubmed-meshheading:21292718-Child,
pubmed-meshheading:21292718-Child, Preschool,
pubmed-meshheading:21292718-Female,
pubmed-meshheading:21292718-Humans,
pubmed-meshheading:21292718-Infant,
pubmed-meshheading:21292718-Influenza, Human,
pubmed-meshheading:21292718-Influenza A Virus, H1N1 Subtype,
pubmed-meshheading:21292718-Influenza Vaccines,
pubmed-meshheading:21292718-Male,
pubmed-meshheading:21292718-Middle Aged,
pubmed-meshheading:21292718-Pandemics,
pubmed-meshheading:21292718-Sentinel Surveillance,
pubmed-meshheading:21292718-Treatment Outcome,
pubmed-meshheading:21292718-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.
|
|
pubmed:affiliation |
British Columbia Centre for Disease Control, Vancouver, BC, Canada. danuta.skowronski@bccdc.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
